β All ComparisonsKRXKRX
Healthcare
Celltrion
068270VS
Samsung Biologics
207940Biosimilars vs CMO - comparing two pillars of Korean bio industry
Celltrion
068270β©190,000
β² 3,000 (+1.60%)
Korea's largest biosimilar company. Global sales of blockbuster biosimilars including Remsima and Truxima.
Samsung Biologics
207940β©850,000
β² 12,000 (+1.43%)
World's largest biopharmaceutical CMO/CDMO. Secured global No.1 production capacity with Plant 4 operational.
Key Metrics Comparison
Celltrion
Key Metrics Comparison
Samsung Biologics
β©190,000
Price
β©850,000
+1.60%
Change
+1.43%
22.7
P/E Ratio
55.8
β©40.8μ‘°
Market Cap
β©60.2μ‘°
β©230,000
52W High
β©1,020,000
β©165,000
52W Low
β©720,000
1.3M
Volume
95K
About the Companies
Celltrion
Korea's largest biosimilar company. Global sales of blockbuster biosimilars including Remsima and Truxima.
Samsung Biologics
World's largest biopharmaceutical CMO/CDMO. Secured global No.1 production capacity with Plant 4 operational.
β» All data is for reference only and not real-time. Investment decisions are the sole responsibility of the investor. This comparison is not investment advice.
Other Comparisons
Eli Lilly & Co. vs UnitedHealth Group
Healthcare
Celltrion vs Eli Lilly & Co.Healthcare
Samsung Biologics vs UnitedHealth GroupHealthcare
Samsung Electronics vs Celltrionblue-chip
SK Hynix vs Celltrionblue-chip
NAVER vs Celltrionblue-chip
Kakao vs Celltrionblue-chip
Hyundai Motor vs Celltrionblue-chip
LG Energy Solution vs Celltrionblue-chip